These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23751367)

  • 1. A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals.
    Hoenen T; Groseth A; Callison J; Takada A; Feldmann H
    Antiviral Res; 2013 Sep; 99(3):207-13. PubMed ID: 23751367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.
    Uebelhoer LS; Albariño CG; McMullan LK; Chakrabarti AK; Vincent JP; Nichol ST; Towner JS
    Antiviral Res; 2014 Jun; 106():86-94. PubMed ID: 24713118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.
    Li D; Chen T; Hu Y; Zhou Y; Liu Q; Zhou D; Jin X; Huang Z
    J Virol; 2016 Oct; 90(19):8720-8. PubMed ID: 27440895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
    Welch SR; Guerrero LW; Chakrabarti AK; McMullan LK; Flint M; Bluemling GR; Painter GR; Nichol ST; Spiropoulou CF; Albariño CG
    Antiviral Res; 2016 Dec; 136():9-18. PubMed ID: 27771389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
    Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
    Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luciferase-Expressing Ebolaviruses as Tools for Screening of Antivirals.
    Hoenen T
    Methods Mol Biol; 2017; 1628():189-194. PubMed ID: 28573620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.
    Alfson KJ; Worwa G; Carrion R; Griffiths A
    J Virol; 2015 Dec; 90(5):2345-55. PubMed ID: 26676781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
    Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
    Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein.
    Albariño CG; Wiggleton Guerrero L; Lo MK; Nichol ST; Towner JS
    Virology; 2015 Oct; 484():259-264. PubMed ID: 26122472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Screening of Multiple Compounds against Ebola Virus.
    Dowall SD; Bewley K; Watson RJ; Vasan SS; Ghosh C; Konai MM; Gausdal G; Lorens JB; Long J; Barclay W; Garcia-Dorival I; Hiscox J; Bosworth A; Taylor I; Easterbrook L; Pitman J; Summers S; Chan-Pensley J; Funnell S; Vipond J; Charlton S; Haldar J; Hewson R; Carroll MW
    Viruses; 2016 Oct; 8(11):. PubMed ID: 27801778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening.
    Towner JS; Paragas J; Dover JE; Gupta M; Goldsmith CS; Huggins JW; Nichol ST
    Virology; 2005 Feb; 332(1):20-7. PubMed ID: 15661137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of a cell-based filovirus entry inhibitor evaluation system].
    Chen Q; Guo Y
    Yao Xue Xue Bao; 2015 Dec; 50(12):1538-44. PubMed ID: 27169274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
    Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():1803. PubMed ID: 30147687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
    Kroeker A; Griffin BD; Qiu X; Kobinger G
    Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
    Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
    Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
    mBio; 2018 May; 9(3):. PubMed ID: 29717011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection
    Kummer S; Lander A; Goretzko J; Kirchoff N; Rescher U; Schloer S
    Emerg Microbes Infect; 2022 Dec; 11(1):195-207. PubMed ID: 34919035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.